Insulet Corporation

Insulet Corporation, headquartered in Massachusetts, is an innovative medical device company founded in 2000. The company is dedicated to simplifying life for people with diabetes and other conditions through its Omnipod product platform. This platform provides a unique alternative to traditional insulin delivery methods with its simple, wearable design, offering up to three days of non-stop insulin delivery without the need to see or handle a needle. The company has a customer-centric focus, supplying high-quality products and expanding the use of insulin pump therapy. Insulet's Omnipod products are available in 20+ countries globally. The company recently received a $60.00M Post-IPO Debt investment from Deerfield on 16 March 2009. Insulet also leverages the unique design of its Pod by tailoring its Omnipod technology platform for the delivery of non-insulin subcutaneous drugs across other therapeutic areas. The company's commitment to innovative technology that improves the lives of people with diabetes is evident in its slogan, "Creating a better world through innovative technology that improves the lives of people with diabetes. #Podders". It's worth noting that there is a HIRING SCAM ALERT associated with the company, and candidates should be cautious of fraudulent interviews and job offers purportedly from Insulet. The company has provided guidelines to protect individuals from these scam artists and has urged anyone with doubts about job offers or suspicious communications to reach out directly. If any inappropriate or suspicious communication is received on behalf of Insulet, it is encouraged to be reported to www.iC3.gov or www.stopfraud.gov.